Riversource Lasalle International Real Estate Fund, Inc. (SLS)

Sector:
FINANCE
Industry:
REAL ESTATE & REITS
SIC:
CEO:
Angelos M. Stergiou
Employees:
10
315 MADISON AVENUE, 4TH FLOOR, NEW YORK, NY 10017
(813) 864-4523

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

SELLAS Life Sciences Group, Inc. focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapy that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials. The company was founded in 2012 and is headquartered in New York, New York.

Data derived from most recent annual or quarterly report
Market Cap 0 Shares Outstanding0 Avg 30-day Volume 61.215 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.45
Price to Revenue41.5359 Debt to Equity0.0 EBITDA-39.174 Million
Price to Book Value3.2973 Operating Margin-4412.3 Enterprise Value20.088 Million
Current Ratio1.801 EPS Growth0 Quick Ratio1.701
1 Yr BETA 0.9737 52-week High/Low 0.0 / Profit Margin-3877.8
Operating Cash Flow Growth-34.1184 Altman Z-Score-11.8059 Free Cash Flow to Firm -21.809 Million

Are you looking for this stock instead?

View SEC Filings from SLS instead.

View recent insider trading info

Funds Holding SLS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SLS

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MOORE COLIN VICE PRESIDENT

  • Officer
  • CIO, ISSUER'S INV. ADVISER
0 2010-05-01 0

CONNAUGHTON J KEVIN PRESIDENT

  • Officer
  • SVP, ISSUER'S INV. ADVISER
0 2010-05-01 0

PETERS JEFFREY FRANKLIN

  • SVP, ISSUER'S INV. ADVISER
0 2010-05-01 0

WONDRACK LINDA

  • CCO, ISSUER & INV. ADVISER
0 2010-05-01 0

UNCKLESS AMY L.

  • CAO, ISSUER'S INV. ADVISER
0 2010-05-01 0

MCCONNAUGHEY ROBERT K.

  • SVP, ISSUER'S INV. ADVISER
0 2010-05-01 0

LUNDGREN COLIN JAMES

  • SVP, ISSUER'S INV. ADV.
0 2010-05-01 0

JONES MICHAEL A. VICE PRESIDENT

  • Officer
  • PRESIDENT, ISSUER'S INV. ADV.
0 2010-05-01 0

BROWN BETH ANN

  • SVP, ISSUER'S INV. ADVISER
0 2010-05-01 0

THOMPSON CHRISTOPHER C.

  • SVP, ISSUER'S INV. ADVISER
0 2010-05-01 0

ALISON TAUNTON-RIGBY

  • Director
245 2008-11-13 0

FLYNN PATRICIA M

  • Director
100 2008-11-13 0

LEWIS STEPHEN R JR

  • Director
100 2008-11-13 0

PAGLIA CATHERINE JAMES

  • Director
100 2008-11-13 0

ANGELOS JAMES F

  • VP, ISSUER'S INV. ADV.
0 2008-11-13 0

TRUSCOTT WILLIAM F VICE PRESIDENT

  • Officer
  • Director
100 2008-11-13 0

PLUMMER SCOTT R VP, GC AND SECRETARY OF ISSUER

  • Officer
0 2008-11-13 0

GALLUS PETER A.

  • CAO, ISSUER'S INV. ADV.
0 2008-11-13 0

BANNIGAN PATRICK T. PRESIDENT

  • Officer
0 2008-11-13 0

FOX JEFFREY P. ASSISTANT TREASURER OF ISSUER

  • Officer
0 2008-11-13 0

LAMMERS JENNIFER D.

  • CCO, ISSUER & INV. ADV.
0 2008-11-13 0

KEATING CHRISTOPHER P.

  • DIRECTOR, ISSUER'S INV. ADV.
0 2008-11-13 0

JOHNSON AMY K. VICE PRESIDENT

  • Officer
0 2008-11-13 0

KEELEY MICHELLE M. VICE PRESIDENT

  • Officer
0 2008-11-13 0

MCGRANE BRIAN J.

  • CFO & DIR., ISSUER'S INV. ADV.
0 2008-11-13 0

CARLTON PAMELA G

  • Director
100 2008-11-13 0

BLATZ KATHLEEN

  • Director
100 2008-11-13 0

CARLSON ARNE H

  • Director
100 2008-11-13 0

LAIKIND JEFFREY

  • Director
100 2008-11-13 0

JONES ANNE PATRICIA

  • Director
100 2008-11-13 0

GOUCHER PAUL B. SECRETARY OF ISSUER

  • Officer
  • DIRECTOR, ISSUER'S INV. ADV.
0 2008-07-07 0

GALVIN JOHN R

  • Director
538 2007-09-28 0

RICHIE LEROY C

  • Director
500 2007-09-27 0

SHAFER ROBERT L

  • Director
1,000 2007-09-27 0

MAHER JOHN F

  • Director
1,000 2007-09-26 0

MORRIS WILLIAM C

  • Director
  • CHAIR/DIR., ISSUER'S INV. ADV.
31,300 2007-09-24 0

MCPHERSON FRANK A

  • Director
500 2007-09-21 0

WHITSON JAMES N

  • Director
500 2007-08-29 0

ZINO BRIAN T PRESIDENT AND CEO

  • Officer
  • Director
1,000 2007-08-16 0

PAULEY KEITH R

  • PORTFOLIO MANAGER
3,075 2007-08-16 0

FONSECA MAUREEN

  • Director
25 2007-07-27 0

MICHEL BETSY

  • Director
1,000 2007-07-20 0

MOLES THOMAS G

  • DIRECTOR OF ISSUER'S INV. ADV.
0 2007-05-24 0

SMITH RODNEY G D

  • DIRECTOR OF ISSUER'S INV. ADV.
0 2007-05-24 0

STEIN DAVID F

  • DIRECTOR OF ISSUER'S INV. ADV.
0 2007-05-24 0

WICK PAUL H

  • DIRECTOR OF ISSUER'S INV. ADV.
0 2007-05-24 0

NASTA FRANK J SECTRETARY, ISSUER & ADVIS.

  • Officer
0 2007-05-24 0

ROSE THOMAS G VP OF ISSUER

  • Officer
  • CFO OF ADVISER
0 2007-05-24 0

VOGEL LAWRENCE P VP, TREAS. ISSUER/SVP ADVISER

  • Officer
0 2007-05-24 0

KADLEC CHARLES W

  • DIRECTOR OF ISSUER'S INV. ADV.
0 2007-05-24 0

EIGEN NEIL T

  • DIRECTOR, ISSUER'S INV. ADV.
0 2007-05-24 0

CLARK JOHN H

  • DIRECTOR, ISSUER'S INV. ADV.
0 2007-05-24 0

PISANO ALBERT A

  • CCO, ISSUER'S INVEST. ADVISER
0 2007-05-24 0

HOAGLAND ELEANOR T M CHIEF COMPLIANCE OFFICER

  • Officer
0 2007-05-24 0

CUNNINGHAM JOHN B

  • DIRECTOR, CIO ISSUER'S ADVISER
0 2007-05-24 0

LEEUW ERNST-JAN DE

  • PORTFOLIO MANAGER
0 2007-05-24 0

NOON GEORGE J

  • PORTFOLIO MANAGER
0 2007-05-24 0

KRASKA STANLEY J JR

  • PORTFOLIO MANAGER
0 2007-05-24 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments